Loading clinical trials...
Loading clinical trials...
PCSK9 and Lipid Metabolism in Sepsis (PALMS) : a Two-center, Phase 1b Randomized, Placebo-controlled, Double-blind, Clinical Trial of Alirocumab in Patients with Sepsis
Conditions
Interventions
Alirocumab
Placebo
Locations
2
United States
Grady Memorial Hospital
Atlanta, Georgia, United States
Emory University Hospital
Atlanta, Georgia, United States
Start Date
January 4, 2023
Primary Completion Date
February 18, 2025
Completion Date
February 23, 2025
Last Updated
March 24, 2025
NCT06712641
NCT07533994
NCT07367113
NCT07356583
NCT06517810
NCT07172451
Lead Sponsor
Jonathan Sevransky
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions